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Rat brain microtubules were prepared at the adult stage and from immature (i.e., 4-day-old) animals. At 
an early stage of development, the composition of microtubule-associated proteins is qualitatively different 
from that found at the adult stage [(1982) Eur. J. Biochem. 129, 465-4711. The influence of calmodulin 
on the time course of assembly of second cycle microtubules was compared at both stages of brain 
development (i.e., microtubules originating from 4-day-old and adult animals). In the presence of Ca2+ 
the inhibition of microtubule assembly was more pronounced at a young stage of brain development han 
at the adult stage. Cross-linking studies with ‘251-labeled calmodulin further established that the two major 
microtubule-associated proteins, MAP2 and TAU were able to bind to calmodulin at both stages of brain 
development but with different intensities. The labeling with ‘251-labeled calmodulin was Ca2+-dependent, 
specific, displaced by unlabeled calmodulin and trifluoperazine. 
CalmoduIin Microtubule 
1. INTRODUCTION 
Several lines of evidence suggest hat Ca’+-cal- 
modulin regulates microtubule assembly both in 
the intact cell [l-4] and under in vitro conditions 
[ 1,581. With purified microtubules millimolar 
concentrations of Ca2+ are required to inhibit 
assembly in the absence of calmodulin; in contrast, 
the sensitivity to Ca2+ is increased by two orders of 
magnitude in the presence of calmodulin. Since 
such an enhancement in Ca2+ sensitivity was 
demonstrated in preparations that contained both 
tubulin and MAPS, studies have been performed to 
identify which one of these components interacts 
with calmodulin. 
As an interaction between calmodulin and tubu- 
lin [9] has not been confirmed [5,9], several 
Abbreviations: MAPS, microtubule-associated proteins; 
MAP2, high-molecular-mass microtubule-associated pro- 
tein; TAU, another microtubule-associated protein(s); 
Mes, 4-morpholineethanesulfonic acid 
Rat brain development 
attempts have been made to identify which one of 
the MAPS is involved. For instance authors in [lo] 
have found that one of the MAPS, the TAU pro- 
teins (60-70 kDa) bind to a calmodulin-Sepharose 
affinity column whereas the high-molecular-mass 
component MAP2 (300-350 kDa) does not. In 
contrast authors in [6] have reported that MAP2 
binds to calmodulin more efficiently than TAU 
proteins. Authors in [ll], on the basis of kinetic 
experiments, have also proposed that Ca’+-cal- 
modulin interacts with one or more of the MAPS: 
since, in the absence of MAPS, tubulin polymerizes 
very poorly the formation of a ternary complex 
between Ca2+,’ calmodulin and MAPS would pre- 
vent microtubule assembly. Very recently, it has 
been reported that Ca2+ -calmodulin binds to both 
MAP2 and TAU proteins [ 121. 
All the experiments reported above have been 
performed with microtubules and MAPS prepared 
from adult rat brain. Microtubules can be also pre- 
pared at different stages of development, i.e., 
when the brain is immature or during the critical 
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period of nerve cell differentiation [ 131. During 
these periods the composition of MAPS differs 
markedly from that found at the adult stage [14]. 
For instance, the group of proteins of 60-70 kDa 
(TAU proteins) differ in composition, activity and 
peptide mapping depending on whether they are 
prepared at early or adult stages of development 
1151. 
It is not known therefore whether calmodulin 
also regulates microtubule assembly in the im- 
mature brain, and by which mechanism(s). To 
answer these questions kinetic and cross-linking 
experiments were performed to determine whether 
calmodulin inhibits the assembly of microtubules 
prepared at early stages of brain development, and 
whether it interacts with one or more of the dif- 
ferent MAPS which copolymerize with micro- 
tubules prepared from immature rat brain. 
2. MATERIALS AND METHODS 
2. I. Materials 
Sephacryl S-200 and low-molecular-mass calibra- 
tion protein kit were from Pharmacia. Mes, GTP, 
EDTA and EGTA were from Sigma; SDS, acryl- 
amide and bisacrylamide were purchased from Bio- 
Rad. Trifluoperazine was a gift from Smith, Kline 
and French. Dimethylsuberimidate was from Serva, 
lactoperoxidase and glucose oxidase from Calbio- 
them. Rat brain microtubules were purified by the 
temperature-dependent assembly-disassembly pro- 
cedure [ 161. MAPS were prepared as in [17]. Cal- 
modulin was prepared as in [ 181 in which in the last 
step of gel filtration, Sephadex G-100, was replaced 
by Sephacryl S-200. Calmodulin was dialyzed 
against deionized water, lyophilized and stored at 
-70°C. 
2.2. Time course of tubulin polymerisation 
Tubulin polymerisation in vitro at 37°C was fol- 
lowed by turbidity development at 350nm under 
the conditions in [13]. 
2.3. Cross-linking of MAPS with ‘251-labeled cal- 
modulin 
Iodination of calmodulin (0.2 mg) was performed 
at 23°C in 0.05 M phosphate buffer (pH 7.0), con- 
taining 1 pug lactoperoxidase, 34pg glucose and 
0.4mM CaClz (final volume 0.17 ml). Na12’I 
(0.1 mCi, Amersham) in 1~1 was mixed with 10~1 
KI (10 mM). A 2~1 aliquot of this solution (20 nmol 
I-) was added to the incubation mixture and the 
reaction was initiated by addition of 5~1 glucose 
oxidase (1 mg/ml). After 45 min incubation, the 
reaction was stopped by addition of 5~1 dithio- 
threitol (100 mg/ml) ‘251-labeled calmodulin was 
purified on a Sephadex G-100 column, equili- 
brated and eluted with 0.05 M triethanolamine 
(pH 8.5), 0.5 mM MgClz. A single major homo- 
geneous band that comigrated with unmodified 
calmodulin was detected by overloaded SDS-poly- 
acrylamide gel electrophoresis (SDS-PAGE). The 
ability of 1251-labeled calmodulin to stimulate a 
calmodulin-sensitive cyclic nucleotide phosphodi- 
esterase from bovine brain was similar to that of 
the unlabeled calmodulin (not shown). 
MAPS from 4-day-old and adult rat brains were 
dialyzed against 0.2 M triethanolamine (pH 8.5) 
containing 1 mM MgCl2 and 0.1 mM dithiothreitol 
at 4°C. Cross-linking [19] in 25~1 with 1OrM 1251- 
labeled calmodulin and 0.4-l mg/ml of MAPS (or 
other proteins, see section 3) in 0.2M triethanol- 
amine (pH 8.5), 2 mM MgCl2, 2 mM dithiothreitol 
and either 1 mM CaCl2 or 1 mM EGTA was initiated 
by 2~1 of a fresh solution containing 25 mg/ml of 
dimethylsuberimidate in 0.2 M triethanolamine 
(pH 8.5). 
The samples were incubated for 60 min at 23°C. 
The reaction was terminated by adding 5~1 of a 
mixture consisting of 8% SDS and 18% 2-mer- 
captoethanol and boiling for 2 min. The samples 
were subjected to SDS-PAGE as in [ 151. After 
Coomassie blue staining, the wet gels were auto- 
radiographed on Kodak X-AR5 X-ray films. 
Protein concentration was determined as in [20] 
with bovine serum albumin as standard, as well 
as by UV absorption for purified calmodulin 
(~M,ZN = 3240) Pll. 
3. RESULTS AND DISCUSSION 
Kinetic experiments were performed to establish 
whether Ca2+-calmodulin i hibits the assembly of 
second cycle microtubules prepared at early stages 
of rat brain development. Fig.lB shows that low 
concentrations of either Ca2+ (- 1OOpM free Ca’+) 
or calmodulin (lOpM), when used separately, had 
only trivial effects on the time course of assembly 
of second cycle microtubules prepared from adult 
rat brain. In contrast, with 4-day-old microtubules 
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Fig. 1. Ca*+-calmodulin-induced inhibition of tubulin 
polymerisation: comparison between 4-day-old (A) and 
adult (B) microtubules. Microtubules (1.3 mg/ml) pre- 
pared from 4-day-old (A) and adult (B) rat brains were 
polymerized at 37°C as described in section 2 with the 
following additions: (A) none, (A) 1OpM calmodulin, 
(0) 1.25mM Ca*’ in (A) or 1.5 mM Ca*+ in (B); (0) 
1.25 mM Ca*+ in (A) or 1.5 mM Ca*+ in (B) plus 1OpM 
calmodulin. 
(fig.lA), the effects of Ca*+ alone seemed to be 
more significant than with the adult preparation. 
Combining Ca*+ and calmodulin resulted in a 
marked reduction in the initial rate and overall 
assembly and in an increase in the lag period at 
both stages; in addition, the effect of Ca*+-cal- 
modulin on the polymerisation of 4-day-old micro- 
tubules appears to be much more pronounced than 
that observed with adult microtubules. The latter 
conclusion was also reached at lower (l-5sM) 
concentration of calmodulin (not shown). 
It has been shown that the composition of the 
MAPS prepared at different stages of brain de- 
velopment is clearly different when these proteins 
are analyzed by SDS-PAGE. Two major groups 
of MAPS, MAP2 (or HMW2) and TAU, have been 
identified at an adult stage on the basis of their 
molecular masses on SDS gels which are -350 kDa 
and -70 kDa, respectively [22-241. The TAU frac- 
tion is itself composed of 4 closely spaced bands 
which produce very similar peptide maps when 
treated with Streptococcus aureus protease [24]. In 
contrast, the peptide map of MAP2 is very dif- 
ferent from that of TAU [15]. 
At young stages the high-molecular-mass com- 
ponent, MAP*, has a peptide map different from 
that of the adult one [15]. On the other hand, the 
young TAU entities are resolved by one-dimen- 
sional SDS-PAGE into two bands of 50 kDa 
(‘fast’ TAU) and 63 kDa (‘slow’ TAU) with none 
migrating as any of the 4 adult entities. Finally, 
fast and ‘young’ TAUs produce completely dif- 
ferent peptide maps [ 151. 
Cross-linking experiments revealed that both 
adult MAP2 and adult TAU interact with Ca*+- 
calmodulin (fig.2). This result is in agreement with 
the conclusions in [12]. The covalent complex 
formed between TAU and calmodulin has, as ex- 
pected, an apparent molecular mass higher than 
that of free TAU. Since MAP2 is a much larger 
protein, an increment in its molecular mass after 
cross-linking with calmodulin could not be calcu- 
lated. 
Similar cross-linking experiments performed 
with young MAPS led to similar conclusions: both 
MAP2 and TAU were labeled by 1251-labeled cal- 
modulin (fig.2). The pattern of labeling in the 
young TAU region was also different from that ob- 
tained with adult TAU. Two cross-linked and 
labeled polypeptides were clearly separated; their 
molecular masses were equal to 67 kDa and 80 kDa, 
respectively, i.e., 17 kDa higher than the two 
parent young TAU proteins which have a mole- 
cular mass of 50 kDa (fast TAU) and 63 kDa (slow 
TAU). This indicates the formation of a 1: 1 com- 
plex between fast or slow TAU and calmodulin. A 
1: 1 stoichiometry has also been reported using 
similar cross-linking techniques for the myosin 
kinase, whereas for the calmodulin-sensitive phos- 
phodiesterase the ratio is 2 per mol enzyme, i.e., 
one for each one of the two subunits of that phos- 
phodiesterase [25]. 
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Fig.2. Cross-linking of MAPS from 4-day-old and adult 
rat brain microtubules to “‘I-labeled calmodulin. The 
cross-linking reaction with 1OpM ‘251-labeled calmo- 
dulin and 50 pg dimethylsuberimidate in the presence of 
either 1 mM CaC12 (lanes 1,3,5,7) or 1 mM EGTA (lanes 
2,4,6,8) was followed by SDS- PAGE and autoradio- 
graphy as described in section 2: (lanes 1,2) ‘ZSI-labeled 
calmodulin in the absence of any protein; (lanes 3,4) 
‘Z51-labeled calmodulin in the presence of 0.4 mg/ml 
MAPS from 4-day-old rat brain microtubules; lz51- 
labeled calmodulin in the presence of MAPS of adult rat 
brain microtubules, respectively, at 0.8 mg/ml (lanes 
5,6) and 1 mg/ml (lanes 7,8). The apparent molecular 
masses of MAPS, calmodulin and its cross-linked pro- 
ducts were determined using phosphorylase b (94 kDa), 
albumin (67 kDa), ovalbumin (43 kDa), carbonic 
anhydrase (30 kDa), trypsin inhibitor (20 kDa) 
as standards in SDS-PAGE. CaM, calmodulin. 
Thus although young and adult TAUs are prob- 
ably different proteins, as shown both by peptide 
mapping [ 151 and after isolation of their mRNA 
[26], they share the property of interacting with 
Ca2+-calmodulin. 
In the region corresponding to young MAP2 
cross-linking complexes were also repeatedly ob- 
served but the labeling of this entity was always 
much less pronounced than that of the adult MAP2 
species. In contrast, labeling of young TAU pro- 
teins was always more pronounced than that of 
adult TAU. 
As a criterium of specificity, the cross-linking 
reaction was also carried out in the presence of 
1 mM EGTA to complex all the free Ca2+ present 
in the medium. Fig.2 shows that the labeling of the 
different young and adult MAPS by ‘2SI-labeled 
calmodulin was almost abolished under these con- 
ditions. Thus, the Ca2+-saturated form of calmodu- 
lin is readily cross-linked with MAPS whereas the 
(operationally defined) Ca2+-free form of this pro- 
tein is not. The cross-linking reaction was inhibited 
by a large excess of unlabeled calmodulin (not 
shown). 
In the presence of Ca2+, trifluoperazine is known 
to bind to calmodulin, presumably through a 
hydrophobic type of interaction and thereby to in- 
hibit the interaction between this Ca2+-binding 
protein and several calmodulin-dependent proteins 
or enzymes [27]. When MAPS prepared from both 
4-day-old and adult brain microtubules were incu- 
bated in the presence of 1251-labeled calmodulin, 
Ca2+ and dimethylsuberimidate he labeling of the 
cross-linked polypeptides was partially decreased 
in the presence of 50pM trifluoperazine and almost 
completely displaced in the presence of IOOpM of 
the same drug (fig.3). 
Finally, the specificity of the MAPS-calmodulin 
cross-linking reaction was tested by incubating 
several other proteins (phosphorylase 6, serum 
albumin, ovalbumin, carbonic anhydrase, trypsin 
inhibitor, cY-lactalbumin) with the cross-linking 
reagent and calmodulin. Under the experimental 
conditions of fig.2, only serum albumin was slightly 
labeled, a result (not shown) that might be ex- 
plained by the fact that this protein is hydrophobic 
and may therefore interact slightly with calmodu- 
lin which is also hydrophobic. 
In conclusion, our data show that: 
(i) The Ca’+-calmodulin complex inhibits the 
assembly of microtubules prepared at young stages 
of brain development. At this stage in the rat 
brain, the neurons of the cortex are already formed 
but not differentiated, whereas in the cerebellum 
neuronal proliferation only begins after birth. It is 
interesting in these respects that calmodulin anti- 
bodies decorate the microtubules of the spindle in 
the dividing cells [28]. 
(ii) Both at a young and at an adult stage the two 
main groups of MAPS, MAP2 and TAU, form 
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Fig.3. Effect of trifluoperazine on the cross-linking 
efficacy of MAPS to ‘2S1-labeled calmodulin. The cross- 
linking reaction with 1OpM ‘251-labeled calmodulin and 
5Opg dimethylsuberimidate (except lane 1) was allowed 
to proceed in the presence of 1 mM CaCl2 with the fol- 
lowing: (lanes 1,2) r2’I-labeled calmodulin in the absence 
of any protein (lane 1: no cross-linker); (lanes 3-5) ‘251- 
labeled calmodulin in the presence of 0.4 mg/ml MAPS 
from 4-day-old rat brain microtubules; (lanes 6-8) 1251- 
labeled calmodulin in the presence of 0.7 mg/ml MAPS 
from adult rat brain microtubules with the addition of 
OmM (lanes 3,6), 50pM (lanes 4,7) and 1OOpM (lanes 
5,8) trifluoperazine. CaM, calmodulin. 
cross-linked derivatives with Ca2+-calmodulin. 
Based on experiments with young TAU we propose 
a 1: 1 stoichiometry. This result provides direct 
proof of the proposal made in [l l] that the inhibi- 
tion of microtubule assembly by Ca2+-calmodulin 
results from the formation of a ternary complex 
between this protein and MAPS. It also implies 
that the Ca2+-calmodulin-MAPS complex is in- 
active in promoting tubulin assembly. In other 
words, calmodulin and tubulin seem to compete 
for the binding to MAPS. This is consistent with 
the observation that the concentration of calmodu- 
lin required to inhibit microtubule assembly is 
approximately equimolar with that of tubulin. 
(iii) In contrast to the conclusions in [lo] but in 
agreement with the recent data in [12], not only 
adult TAU but also adult MAP2 interact with cal- 
modulin. 
(iv) The labeling of adult MAP2 by ‘251-labeled cal- 
modulin always seems stronger than that of adult 
TAU. The situation appears to be reversed at early 
stages of brain development since the cross-linking 
reaction is systematically less efficient with young 
MAP2 than with young TAU. It is not known 
whether the stronger inhibition of microtubule 
assembly by Ca2+-calmodulin observed at young 
stages of development (fig. 1) is related to these dif- 
ferences in cross-linking efficiency. 
Irrespective of the answer to this question, it 
remains that most of the young and adult MAPS 
seem to be able to interact with Ca2+-calmodulin. 
This suggests a fundamental function of MAPS as 
target proteins for Ca2+-calmodulin. Although the 
various young and adult MAPS are probably dif- 
ferent proteins with different cellular functions, it 
is nevertheless conceivable that they might all share 
a similar domain responsible for the interaction 
with calmodulin. 
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